Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1973 May 5;2(5861):261–265. doi: 10.1136/bmj.2.5861.261

Early Warning of Rejection?

J M Wellwood, B G Ellis, J H Hall, D R Robinson, A E Thompson
PMCID: PMC1589177  PMID: 4574344

Abstract

The urinary excretion of N-acetyl-β-D-glucosaminidase (NAG), β-galactosidase (GAL), β-glucosidase (GLU), and alkaline phosphatase (AP) was studied in 83 patients with renal allografts. Thirty of these patients had stable graft function and their urinary enzyme levels provided a range of normal values. Urinary lactic dehydrogenase (LDH) was estimated in 29 normal subjects and in 11 patients with renal allografts. Serum values for the five enzymes were also obtained. Urinary NAG excretion was abnormally high in 16 out of 17 (94%) episodes of acute rejection. The other urinary enzymes were raised less frequently. In nine patients studied before the onset of rejection urinary NAG activity rose up to three weeks before changes in other tests of renal function. Serum enzyme levels were not found to be of value in the diagnosis of rejection.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMADOR E., DORFMAN L. E., WACKER W. E. SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS. Clin Chem. 1963 Aug;12:391–399. [PubMed] [Google Scholar]
  2. Ballantyne B., Wood W. G., Meffan P. M. Sequential analysis of urinary enzymes in early diagnosis of parenchymal damage after renal homotransplantation. Br Med J. 1968 Jun 15;2(5606):667–669. doi: 10.1136/bmj.2.5606.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braun W. E., Merrill J. P. Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med. 1968 Jun 20;278(25):1366–1371. doi: 10.1056/NEJM196806202782503. [DOI] [PubMed] [Google Scholar]
  4. Dance N., Price R. G., Cattell W. R., Lansdell J., Richards B. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with renal disease. Clin Chim Acta. 1970 Jan;27(1):87–92. doi: 10.1016/0009-8981(70)90378-5. [DOI] [PubMed] [Google Scholar]
  5. Hamburger J. The immunological follow up of renal allograft recipients. Proc R Soc Med. 1972 Dec;65(12):1051–1056. [PMC free article] [PubMed] [Google Scholar]
  6. LEABACK D. H., WALKER P. G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961 Jan;78:151–156. doi: 10.1042/bj0780151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Noble R. E., Najarian J. S., Brainerd H. D. Urine and serum lysozyme measurement in renal homotransplantation. Proc Soc Exp Biol Med. 1965 Dec;120(3):737–740. doi: 10.3181/00379727-120-30641. [DOI] [PubMed] [Google Scholar]
  8. PROUT G. R., Jr, MACALALAG E. V., Jr, HUME D. M. SERUM AND URINARY LACTIC DEHYDROGENASE IN PATIENTS WITH RENAL HOMOTRANSPLANTS. Surgery. 1964 Jul;56:283–295. [PubMed] [Google Scholar]
  9. Price R. G., Dance N., Richards B., Cattell W. R. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase following surgery to the kidney. Clin Chim Acta. 1970 Jan;27(1):65–72. doi: 10.1016/0009-8981(70)90375-x. [DOI] [PubMed] [Google Scholar]
  10. Shah B. C., Ambrus J. L., Mink I. B., Albert D. J., Sampson D., Murphy G. P. Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation. 1972 Dec;14(6):705–710. doi: 10.1097/00007890-197212000-00006. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES